Myelodysplasia during the course of myeloma. Restriction of 17p deletion and p53 overexpression to myeloid cells

Leukemia

Volumn 12, Issue 2, 1998, Pages 238-241

  Soenen, V ^a   Preudhomme, C ^a   Roumier, C ^a   Lai J L ^a   Lepelley, P ^a   Facon, T ^b   Pagniez, D ^a   Fenaux, P ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CHU Hôpital Calmette ^*

Author keywords

17p deletion; Multiple myeloma; Myelodysplastic syndrome; p53

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; LOMUSTINE; MELPHALAN; PREDNISONE; PROCARBAZINE; PROTEIN P53; VINCRISTINE;

ADULT; ARTICLE; BONE MARROW CELL; CASE REPORT; CHROMOSOME 17P; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION 17; CHROMOSOME TRANSLOCATION 5; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031932207     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400909     Document Type: Article

References (13)

1. Laï JL, Preudhomme C, Zandecki M, Flactif M, Vanrumbeke M, Wattel E, Fenaux P. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidence of p53 mutations. Leukemia 1995; 9: 370-381.
2. Jary L, Mossafa H, Fourcade C, Genet P, Pulik M, Flandrin G. The 17p syndrome a distinct myelodysplastic syndrome entity? Leuk Lymphoma 1997; 25: 163-168.
3. Bergsagel DE. Plasma cell neoplasms and acute leukemia. Clin Haematol 1982; 11: 221-234.
4. Buckman R, Cuzick J, Gallon DAG. Long-term survival in myelomatosis. Br J Haematol 1982; 52: 589-599.
5. Cuzick J, Erskine S, Edelman D, Gallon DAG. A comparison of the incidence of myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. Br J Cancer 1987; 55: 523-529.
6. Rosner F, Grünwald HW. Simultaneous occurrences of multiple myeloma and acute myeloblastic leukemia: fact or myth? Am J Med 1984; 76: 891-899.
7. Chumakov MI, Rigault P, Le Gall I, Bellanné-Chantelot C, Billault, A et al. A YAC contig map of the human genome. Nature 1995; 377: (Suppl.): 175.
8. Chaffanet M, Imbert A, Adelaïde J, Le Paslier D, Wagner MJ, Wells DE, Birnbaum D, Pébusque MJ. A 3.1-Mb YAC conting within the Werner syndrome region, on the short arm of human chromosome 8. Cytogenet Cell Genet 1996; 72: 63-69.
9. Soenen V, Fenaux P, Flactif M, Lepelley P, Laï JL, Cosson A, Preudhomme C. Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes. Br J Haematol 1995; 90: 701-706.
10. Fenaux P, Jonveaux P, Quiquandon I, Laï JL, Pignon JM, Loucheux-Lefebvre MH, Bauters F, Berger R, Kerckaert JP. P53 gene mutations in acute myeloid leukemia with 17p monosomy. Blood 1991; 78: 1652-1657.
11. Lepelley P, Preudhomme P, Vanrumbeke M, Quesnel B, Cosson A, Fenaux P. Detection of p53 mutation in hematological malignancies: comparison between immunocytochemistry and DNA analysis. Leukemia 1994; 8: 1342-1349.
12. Ligorsky RD, Axelord AR, Mandell GH, Palutke M, Prasad AS. Acute myelomonocytic leukemia in a patient with macroglobulinemia and malignant lymphoma. Cancer 1977; 39: 1156-1162.
13. Barlogie B, Epstein J, Selvanayagom P, Alexaniar R. Plasma cell myeloma. New biological insights and advances in therapy. Blood 1989; 73: 865-879.